Ken Griffin’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,007
| Closed | -$38K | – | 7427 |
|
|
2025
Q1 | $38K | Buy |
+12,007
| New | +$38K | ﹤0.01% | 5442 |
|
|
2024
Q2 | – | Sell |
-856
| Closed | -$42.6K | – | 7158 |
|
|
2024
Q1 | $42.6K | Sell |
856
-1,207
| -59% | -$60.1K | ﹤0.01% | 5359 |
|
|
2023
Q4 | $155K | Buy |
2,063
+1,485
| +257% | +$112K | ﹤0.01% | 4718 |
|
|
2023
Q3 | $48.6K | Buy |
+578
| New | +$48.6K | ﹤0.01% | 5085 |
|
|
2023
Q2 | – | Sell |
-21
| Closed | -$5.92K | – | 6798 |
|
|
2023
Q1 | $5.92K | Sell |
21
-150
| -88% | -$42.3K | ﹤0.01% | 5595 |
|
|
2022
Q4 | $44.7K | Buy |
+171
| New | +$44.7K | ﹤0.01% | 5312 |
|
|
2022
Q3 | – | Sell |
-60
| Closed | -$20K | – | 7043 |
|
|
2022
Q2 | $20K | Buy |
60
+33
| +122% | +$11K | ﹤0.01% | 5723 |
|
|
2022
Q1 | $16K | Sell |
27
-225
| -89% | -$133K | ﹤0.01% | 6172 |
|
|
2021
Q4 | $153K | Sell |
252
-125
| -33% | -$75.9K | ﹤0.01% | 5653 |
|
|
2021
Q3 | $369K | Buy |
377
+166
| +79% | +$162K | ﹤0.01% | 4837 |
|
|
2021
Q2 | $316K | Buy |
211
+124
| +143% | +$186K | ﹤0.01% | 5150 |
|
|
2021
Q1 | $233K | Sell |
87
-120
| -58% | -$321K | ﹤0.01% | 5287 |
|
|
2020
Q4 | $409K | Sell |
207
-3,153
| -94% | -$6.23M | ﹤0.01% | 4013 |
|
|
2020
Q3 | $9.07M | Buy |
3,360
+2,964
| +748% | +$8M | ﹤0.01% | 1152 |
|
|
2020
Q2 | $1.12M | Sell |
396
-549
| -58% | -$1.56M | ﹤0.01% | 2756 |
|
|
2020
Q1 | $2.53M | Buy |
+945
| New | +$2.53M | ﹤0.01% | 2013 |
|
|
2019
Q4 | – | Sell |
-32
| Closed | -$30K | – | 5277 |
|
|
2019
Q3 | $30K | Buy |
+32
| New | +$30K | ﹤0.01% | 4450 |
|
|
2019
Q2 | – | Sell |
-73
| Closed | -$66K | – | 5244 |
|
|
2019
Q1 | $66K | Buy |
73
+32
| +78% | +$28.9K | ﹤0.01% | 4173 |
|
|
2018
Q4 | $35K | Sell |
41
-66
| -62% | -$56.3K | ﹤0.01% | 4157 |
|
|
2018
Q3 | $125K | Buy |
+107
| New | +$125K | ﹤0.01% | 3860 |
|